These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 21372794)

  • 41. Speech in ALS: Longitudinal Changes in Lips and Jaw Movements and Vowel Acoustics.
    Yunusova Y; Green JR; Lindstrom MJ; Pattee GL; Zinman L
    J Med Speech Lang Pathol; 2013 Mar; 21(1):1-13. PubMed ID: 27453680
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Awaji ALS criteria increase the diagnostic sensitivity in patients with bulbar onset.
    Noto Y; Misawa S; Kanai K; Shibuya K; Isose S; Nasu S; Sekiguchi Y; Fujimaki Y; Nakagawa M; Kuwabara S
    Clin Neurophysiol; 2012 Feb; 123(2):382-5. PubMed ID: 21764635
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A multimodal approach to automated hierarchical assessment of bulbar involvement in amyotrophic lateral sclerosis.
    Rong P; Heidrick L; Pattee GL
    Front Neurol; 2024; 15():1396002. PubMed ID: 38836001
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A multidimensional facial surface EMG analysis for objective assessment of bulbar involvement in amyotrophic lateral sclerosis.
    Rong P; Pattee GL
    Clin Neurophysiol; 2022 Mar; 135():74-84. PubMed ID: 35033773
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical features that distinguish PLS, upper motor neuron-dominant ALS, and typical ALS.
    Gordon PH; Cheng B; Katz IB; Mitsumoto H; Rowland LP
    Neurology; 2009 Jun; 72(22):1948-52. PubMed ID: 19487653
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Two Distinct Clinical Phenotypes of Bulbar Motor Impairment in Amyotrophic Lateral Sclerosis.
    Stipancic KL; Yunusova Y; Campbell TF; Wang J; Berry JD; Green JR
    Front Neurol; 2021; 12():664713. PubMed ID: 34220673
    [No Abstract]   [Full Text] [Related]  

  • 47. Impairment of speech intelligibility in men with amyotrophic lateral sclerosis.
    Kent RD; Kent JF; Weismer G; Sufit RL; Rosenbek JC; Martin RE; Brooks BR
    J Speech Hear Disord; 1990 Nov; 55(4):721-8. PubMed ID: 2232752
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Detecting Bulbar Involvement in Patients with Amyotrophic Lateral Sclerosis Based on Phonatory and Time-Frequency Features.
    Tena A; Clarià F; Solsona F; Povedano M
    Sensors (Basel); 2022 Feb; 22(3):. PubMed ID: 35161881
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tongue movements and their acoustic consequences in amyotrophic lateral sclerosis.
    Yunusova Y; Green JR; Greenwood L; Wang J; Pattee GL; Zinman L
    Folia Phoniatr Logop; 2012; 64(2):94-102. PubMed ID: 22555651
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diagnosis and treatment of bulbar symptoms in amyotrophic lateral sclerosis.
    Kühnlein P; Gdynia HJ; Sperfeld AD; Lindner-Pfleghar B; Ludolph AC; Prosiegel M; Riecker A
    Nat Clin Pract Neurol; 2008 Jul; 4(7):366-74. PubMed ID: 18560390
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oral motor functions, speech and communication before a definitive diagnosis of amyotrophic lateral sclerosis.
    Makkonen T; Korpijaakko-Huuhka AM; Ruottinen H; Puhto R; Hollo K; Ylinen A; Palmio J
    J Commun Disord; 2016; 61():97-105. PubMed ID: 27110704
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Digital markers of motor speech impairments in natural speech of patients with ALS-FTD spectrum disorders.
    Shellikeri S; Cho S; Ash S; Gonzalez-Recober C; McMillan CT; Elman L; Quinn C; Amado DA; Baer M; Irwin DJ; Massimo L; Olm C; Liberman M; Grossman M; Nevler N
    medRxiv; 2023 May; ():. PubMed ID: 37205390
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multimodal speech biomarkers for remote monitoring of ALS disease progression.
    Neumann M; Kothare H; Ramanarayanan V
    Comput Biol Med; 2024 Sep; 180():108949. PubMed ID: 39126786
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Disease duration of progression is helpful in identifying isolated bulbar palsy of amyotrophic lateral sclerosis.
    Zhang H; Chen L; Tian J; Fan D
    BMC Neurol; 2021 Oct; 21(1):405. PubMed ID: 34686150
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Frontal dysfunctions of ALS-PBP patients in relation to their bulbar symptoms and rCBF decline.
    Morimoto N; Kurata T; Sato K; Ikeda Y; Sato S; Abe K
    J Neurol Sci; 2012 Aug; 319(1-2):96-101. PubMed ID: 22613760
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Speech network regional involvement in bulbar ALS: a multimodal structural MRI study.
    Shellikeri S; Myers M; Black SE; Abrahao A; Zinman L; Yunusova Y
    Amyotroph Lateral Scler Frontotemporal Degener; 2019 Aug; 20(5-6):385-395. PubMed ID: 31088163
    [No Abstract]   [Full Text] [Related]  

  • 57. Differences in nerve excitability properties between isolated bulbar palsy and bulbar-dominant amyotrophic lateral sclerosis.
    Pyun SY; Kim Y; Oh SI; Bae JS
    Neurol Res; 2020 Feb; 42(2):133-140. PubMed ID: 31928339
    [No Abstract]   [Full Text] [Related]  

  • 58. The efficacy of acoustic-based articulatory phenotyping for characterizing and classifying four divergent neurodegenerative diseases using sequential motion rates.
    Rowe HP; Gochyyev P; Lammert AC; Lowit A; Spencer KA; Dickerson BC; Berry JD; Green JR
    J Neural Transm (Vienna); 2022 Dec; 129(12):1487-1511. PubMed ID: 36305960
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Changes in lingual-alveolar contact pressure during speech over six months in amyotrophic lateral sclerosis.
    Searl J; Knollhoff S
    J Commun Disord; 2017 Nov; 70():49-60. PubMed ID: 29126546
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lingual-Alveolar Contact Pressure During Speech in Amyotrophic Lateral Sclerosis: Preliminary Findings.
    Searl J; Knollhoff S; Barohn RJ
    J Speech Lang Hear Res; 2017 Apr; 60(4):810-825. PubMed ID: 28335033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.